Impact of BMPR2 therapy on downstream cell signalling in a PAH model: a microarray study

dc.contributor.authorHarper, R.L.
dc.contributor.authorReynolds, P.N.
dc.contributor.conferenceThoracic Society of Australia and New Zealand Annual Scientific Meeting (4 Apr 2014 - 9 Apr 2014 : Adelaide, SA)
dc.date.issued2014
dc.descriptionAbstract: Oliv Sig 2 – Oral Presentations TO 046
dc.description.statementofresponsibilityHarper R, Reynolds P
dc.identifier.citationRespirology, 2014, vol.19, iss.Suppl. 2, pp.28-28
dc.identifier.doi10.1111/resp.12262_9
dc.identifier.issn1323-7799
dc.identifier.issn1440-1843
dc.identifier.orcidHarper, R.L. [0000-0003-1465-7372]
dc.identifier.orcidReynolds, P.N. [0000-0002-2273-1774]
dc.identifier.urihttp://hdl.handle.net/2440/103962
dc.language.isoen
dc.publisherWiley
dc.rights© 2014 The Authors Respirology © 2014 Asian Pacific Society of Respirology
dc.source.urihttps://doi.org/10.1111/resp.12262_9
dc.titleImpact of BMPR2 therapy on downstream cell signalling in a PAH model: a microarray study
dc.typeConference item
pubs.publication-statusPublished

Files